2023
Longitudinal Patterns in Testosterone Prescribing After US FDA Safety Communication in 2014
Sankar A, Everhart A, Jena A, Jeffery M, Ross J, Shah N, Karaca-Mandic P. Longitudinal Patterns in Testosterone Prescribing After US FDA Safety Communication in 2014. The Joint Commission Journal On Quality And Patient Safety 2023, 49: 458-466. PMID: 37380503, DOI: 10.1016/j.jcjq.2023.05.003.Peer-Reviewed Original ResearchConceptsCoronary artery diseaseFDA safety communicationPhysician characteristicsLabel prescribingCare physiciansTestosterone prescribingService administrative claims dataNon-primary care physiciansCertain physician characteristicsDrug Administration (FDA) safety communicationPrimary care physiciansAdministrative claims dataCase mix indexTestosterone therapyArtery diseaseTestosterone prescriptionsPrescribing levelsMean agePrescription trendsTeaching hospitalClaims dataPrescription levelsMedicare feePrescribingUS Food
2018
Statewide Inferior Vena Cava Filter Placement, Complications, and Retrievals
Charalel RA, Durack JC, Mao J, Ross JS, Meltzer AJ, Sedrakyan A. Statewide Inferior Vena Cava Filter Placement, Complications, and Retrievals. Medical Care 2018, 56: 260-265. PMID: 29356721, DOI: 10.1097/mlr.0000000000000867.Peer-Reviewed Original ResearchConceptsIVC filter placementFilter placementIVC filtersFilter retrievalIVC filter-related complicationsProphylactic IVC filter placementInferior vena cava filter placementVena cava filter placementFilter-related complicationsPulmonary embolism riskAverage patient ageDrug Administration (FDA) safety communicationRetrospective cohort studyCava filter placementKaplan-Meier analysisAge-adjusted ratesIVC filter retrievalCohort studyPatient agePE occurrencePE ratePE eventsCumulative riskPopulation-level trendsClinical practice